CD40LG and neoplasm: Long-term surviving mice that were initially cured from A20.GL tumor challenge by m1928z-CD40L CAR T cells were injected with CAR-antigen-negative A20.CD19-KO cells to exclude any CAR T cell-mediated antitumor response by persisting CAR T cells (Fig. 4b).